Article Name Invitro & Invivo Diagnostic
Co-Diagnostics, Inc. Secures Dismissal of Class-Action Lawsuit
Court ruling dismisses claims against Co-Diagnostics, reinforcing the company’s commitment to transparency and innovation in molecular diagnostics.
07th March, 2025
Sky Medical Technology Partners with SMS Medical to Distribute Geko™ Device for Post-Orthopedic Surgery Care in the U.S.
The agreement aims to expand access to Geko™, a non-invasive device designed to reduce edema, prevent DVT, and improve recovery after orthopedic procedures.
07th March, 2025
Sebelas Miudella™ Becomes First FDA-Approved Hormone-Free IUD in 40 Years
Offering a long-acting, non-hormonal birth control option, the approval marks a significant milestone in expanding contraceptive choices for individuals seeking hormone-free alternatives.
03rd March, 2025
UK’s MYndspan Partners with MEGIN to Expand Access to High-Precision Brain Scans
Collaboration brings clinical-grade magnetoencephalography (MEG) technology to consumers, launching first brain health center in London.
28th February, 2025
Addiction Prevention Coalition and DisposeRx Expand Opioid Education and Disposal Efforts in Alabama
The initiative strengthens opioid prevention across Alabama by providing communities with vital education and at-home medication disposal solutions to reduce misuse and accidental overdoses.
27th February, 2025
Allwin Medical Devices and Esco Forge Strategic Partnership to Strengthen IVF Solutions and Expand Global Reach
The collaboration enhances Esco's IVF instrument portfolio with Allwin's consumables, offering a comprehensive solution for IVF clinicians and embryologists while expanding market presence in India.
26th February, 2025
ParagonCare Partners with Coreline Soft to Advance AI-Powered Lung Cancer Screening in Australia
Strategic collaboration introduces Coreline Soft’s AI-driven imaging solutions to enhance early lung cancer detection, supporting the National Lung Cancer Screening Program (NLCSP) in Australia.
25th February, 2025
Japan Approves Sarclisa-VRd for Newly Diagnosed Multiple Myeloma Patients
Regulatory green light follows IMROZ Phase 3 study results showing significant progression-free survival benefit
25th February, 2025
EMA Approves Takeda’s TAKHZYRO Pre-Filled Pen for Subcutaneous Administration in Adolescent and Adult HAE Patients
The new 2 mL pre-filled pen option expands individualized treatment choices for hereditary angioedema (HAE) patients, reinforcing Takeda’s commitment to reducing disease burden and improving quality of life.
25th February, 2025
Ginkgo Bioworks Secures €24M EU Grant to Develop Rapid Next-Gen Sequencing for Respiratory Diagnostics
In collaboration with HaDEA and HERA, Ginkgo leads the RANGER project to create a point-of-care metagenomic sequencing device, aiming for 6-hour turnaround diagnostics to revolutionize pandemic preparedness and hospital triage across Europe.
21st February, 2025
UroMems Achieves Major Milestone in First-Ever Smart Implant Study for Female SUI Patientsv
With all female patients in its groundbreaking clinical feasibility study reaching six-month primary endpoints, UroMems' UroActive System marks a transformative step in treating stress urinary incontinence. The AI-powered smart implant, designed to enhance patient quality of life, is now paving the way for expanded adoption in the U.S. and Europe.
21st February, 2025
NaviFUS Leverages Taiwan’s Advanced Chip Technology to Advance Non-Invasive Brain Disorder Treatments
With groundbreaking ultrasound-based solutions for brain cancer and drug-resistant epilepsy, NaviFUS expands its global impact through strategic industry collaborations, clinical breakthroughs, and partnerships with leading healthcare innovators.
20th February, 2025
Zydus Lifesciences & Guardant Health Back India’s First Liquid Biopsy Academy to Advance Precision Oncology
LiS Academy, an independent academic forum led by top oncologists, aims to enhance awareness and adoption of liquid biopsies for personalized cancer care in India.
19th February, 2025
Sanofi’s Merilog Wins FDA Approval as First Rapid-Acting Insulin Biosimilar for Diabetes
The U.S. FDA has approved Merilog (insulin-aspart-szjj), Sanofi’s biosimilar to Novolog, marking a significant step toward expanding access to affordable insulin. The approval strengthens competition in the diabetes treatment market, offering a new rapid-acting insulin option for millions of patients.
17th February, 2025
Erba Transasia Group introduces advanced haematology analyzer in Karnataka
Clinical Symposium held on “Deeper Insights in Haematology”; Erba H7100 brings hope for early and accurate diagnosis of blood disorders
27th January, 2025
Quanterix to acquire Akoya Biosciences, pioneering integrated biomarker detection
Merger combines ultra-sensitive blood and tissue protein analysis into a unified platform.
13th January, 2025
Human Metapneumovirus (HMNPV): Rising Concerns Over a Growing Health Threat
With symptoms mimicking common respiratory illnesses, Human Metapneumovirus (HMNPV) is placing vulnerable populations at risk and straining healthcare systems. Learn the key precautions to stay safe.
06th January, 2025
Medtech Special
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer